Company Filing History:
2 out of 1,928 
2 out of 3,687 
Years Active: 2018
Title: Nidal Muvarak: Innovator in Cancer Treatment
Introduction
Nidal Muvarak is a prominent inventor based in Baltimore, MD (US), known for his significant contributions to cancer treatment methodologies. With a focus on epigenetic therapy, he has developed innovative approaches to enhance the effectiveness of existing cancer treatments.
Latest Patents
Nidal Muvarak holds 2 patents that showcase his groundbreaking work. His latest patents include:
1. **Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in ovarian cancer** - This patent provides methods to treat cancer cells using low doses of DNA demethylating agents and poly ADP ribose polymerase (PARP) inhibitors. It also outlines methods for sensitizing a cell to a PARP inhibitor.
2. **Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in lung cancer** - Similar to his ovarian cancer patent, this invention offers methods to treat cancer cells using low doses of DNA demethylating agents and PARP inhibitors, along with methods for sensitizing a cell to a PARP inhibitor.
Career Highlights
Throughout his career, Nidal Muvarak has worked with esteemed institutions such as the University System of Maryland and The Johns Hopkins University. His work in these organizations has allowed him to advance his research and contribute to the field of cancer treatment.
Collaborations
Nidal has collaborated with notable colleagues, including Feyruz Rassool and Stephen B Baylin. These partnerships have further enriched his research and innovation in cancer therapies.
Conclusion
Nidal Muvarak's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the field of oncology.